- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06850649
Investigation of the Clinical Outcomes of Endocrowns Manufactured From Three Different Materials
The goal of this clinical trial is to examine the durability of endocrowns, created using various materials and manufacturing techniques with a fully digital workflow, and their ability to maintain functionality and aesthetics in the oral cavity.
The main questions it aims to answer were does effect of different materials on clinical success?
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Based on the power analysis, it was determined that restorations would be applied to 11 teeth in each of the three material groups (lithium-disilicate reinforced glass-ceramic, polymer infiltrated ceramic, and 3D-printed permanent hybrid resin) as well as the control group (n=11). A total of 33 teeth received endocrown restorations. Additionally, 11 patients were directly restored with composite resin in molar teeth with MOD cavities.
The digital impressions of the patients receiving endocrown restorations were recorded using an intraoral optical scanner and sent to a specialized dental laboratory. For two of the groups (lithium disilicate-reinforced glass-ceramic, polymer infiltrated ceramic), restorations were fabricated using block milling, while for the third group (permanent hybrid resin), restorations were produced through 3D printing. The restorations were cemented adhesively. The restorations were evaluated using the Modified FDI and Modified USPHS criteria at baseline (0) and at the 6-month follow-up, and the data were subjected to statistical analysis.
At the 6-month evaluation, a statistically significant difference in color match was found between the groups based on the Modified FDI criteria, whereas no statistically significant differences were observed for any of the Modified USPHS criteria. All endocrowns produced with the three different materials survived and showed clinical success at the 6-month follow-up. Nevertheless, additional clinical studies with extended follow-up durations are required.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
İzmir, Turkey, 35100
- Ege University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Must be a lower or upper molar tooth
- Must be periodontal healthy
- There must be at least two axial walls in the relevant tooth
- Gingival steps should be at gum level
- There must be neighboring teeth mesial and distal to the relevant tooth.
- The place where it occludes must be the opposing tooth and the tooth must be a natural or filled tooth without a prosthesis.
- No systemic acut or chronic conditions (Thyroid disease, Alzheimer's Disease, Insulin dependent diabetes, etc.)
Exclusion Criteria:
- Inadequate oral hygiene, bleeding on probing, pocket deeper than 3 mm mobility presence
- Sensitivity to percussion after root canal treatment
- Insufficient enamel tissue remaining in the relevant tooth
- Presence of radiographically abnormal periodontal space
- Teeth with inadequate bone support
- Teeth with root resorption and fracture
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Endocrown Materials
IPS Empress CAD Vita Enamic VarseoSmile Crown Plus
|
IPS Empress CAD Vita Enamic VarseoSmile Crown Plus
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Clinical Outcomes
Time Frame: 6 month
|
Restorations were checked clinically at the time of delivery and 6 months later. A 0.15 mm probe (DEPPELER 150EX, Rolle, Switzerland) was used for the controls. Modified USPHS and modified FDI criteria (revised 2023) were used in the evaluations. The modified USPHS criteria were recorded as Alpha (A), Bravo (B), Charlie (C), Delta (D), and the modified FDI criteria were recorded as very good, good, adequate, unsatisfactory, and failed. 'Surface Luster, Surface and Marginal Staining, Colour match and Translucency, Esthetic Anatomical Form, Fracture Material and Retention, Marginal adaptation as Modified FDI Criteria and Marginal Discoloration, Marginal Integrity, Surface Texture, Wear, Postoperative Sensitivity and Recurrent Caries as Modified USPS Criteria were evaluated. In the study, the headings of the result measurement tables will be created as follows: Comparison of Baseline Modified USPHS Values According to Groups Comparison of Baseline Modified FDI Values According to G |
6 month
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- E-61749811-000-1963653
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on No Systemic Infection
-
International Centre for Diarrhoeal Disease Research...CompletedChildren | Iron Deficiency Anemia | Helicobacter Pylori Infection | Not Severely Malnourished | No Systemic InfectionBangladesh
-
BEIJING YUANBEN INFORMATION CONSULTING CO., LTDCompletedNo Protrusion | No Open Wound | No Severe Allergic Reaction | No Scar | No Tattoo | No Significant Skin DefectChina
-
Chulalongkorn UniversityCompletedPatients With Body Temperature Between 37.8-38.5 | No Sign of Infection | No Liver and Kidney ProblemThailand
-
UPECLIN HC FM Botucatu UnespUnknownAdult | Inclusion Criteria: | No Pregnancy | No Lactation | No MorbidityBrazil
-
PfizerForest LaboratoriesCompletedSystemic InfectionsUnited States
-
Turtle Shell Technologies Pvt. Ltd.Eastside Research AssociatesRecruitingNo Specific Medical Conditions or Disease States | No Specific ConditionsUnited States
-
Wellell Inc. TaiwanRecruitingNo Condition, Healthy Individuals | No Conditions, Aged 20-64Taiwan
-
Assiut UniversityUnknownInfection Systemic
-
BioFire Diagnostics, LLCUnknownSystemic InfectionUnited States
Clinical Trials on endocrowns
-
Nahda UniversityCompletedPaediatric | DentistryEgypt
-
Cairo UniversityNot yet recruiting
-
Cairo UniversityCompleted
-
Cairo UniversityUnknown